Aida Pharmaceuticals, Inc.
AIDA · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Revenue | $29 | $30 | $25 | $16 |
| % Growth | -1.5% | 20.9% | 56.8% | – |
| Cost of Goods Sold | $15 | $14 | $8 | $5 |
| Gross Profit | $15 | $16 | $16 | $11 |
| % Margin | 50.3% | 52.5% | 66% | 70.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $11 | $14 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $12 | $14 | $8 |
| Operating Income | $5 | $4 | $2 | $3 |
| % Margin | 18.6% | 13.3% | 8.6% | 18.3% |
| Other Income/Exp. Net | -$3 | -$2 | -$1 | -$0 |
| Pre-Tax Income | $2 | $2 | $2 | $3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $3 | $1 | $1 | $2 |
| % Margin | 9.4% | 4.9% | 6% | 10.5% |
| EPS | 0.1 | 0.06 | 0.06 | 0.07 |
| % Growth | 66.7% | 0% | -14.2% | – |
| EPS Diluted | 0.1 | 0.06 | 0.06 | 0.07 |
| Weighted Avg Shares Out | 27 | 26 | 23 | 23 |
| Weighted Avg Shares Out Dil | 27 | 26 | 23 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $1 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $1 |
| EBITDA | $7 | $6 | $4 | $4 |
| % Margin | 25.1% | 20.3% | 15.5% | 23.2% |